Dow Up 0.22% Nasdaq Up 0.31%

Novavax, Inc. (NVAX)

-NasdaqGS
5.41 Down 0.03(0.55%) 12:15PM EST - Nasdaq Real Time Price
Prev Close:5.44
Open:5.41
Bid:5.40 x 7300
Ask:5.41 x 6700
1y Target Est:10.07
Beta:1.67
Next Earnings Date:N/A
Day's Range:5.36 - 5.53
52wk Range:3.34 - 6.95
Volume:1,034,764
Avg Vol (3m):3,778,880
Market Cap:1.29B
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVAXDown 0.55%1.29B
MRKUp 1.46%172.82B
NVSUp 1.15%233.79B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):39.69
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Dec-14) :N/A
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback